https://clinicaltrials.gov/ct2/show/NCT03918109?type=Intr&cond=Tinnitus&phase=012345&lupd_s=04%2F03%2F2019&lupd_d=14
Condition : Tinnitus, Subjective
Interventions : Drug: OTO-313; Drug: Placebo
Sponsor : Otonomy, Inc.
Recruiting
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109
Wed, 17 Apr 2019 12:00:00 EDT
